Submission regarding PMPRB's Guideline Monitoring and Evaluation Plan
Date de parution : 07/19/2021 Personne(s)-ressource(s) : Joan WeirThe Canadian Life and Health Insurance Association (CLHIA) is pleased to provide its comments to the Patented Medicine Prices Review Board (PMPRB) as part of the Consultation on the Guideline Monitoring and Evaluation Plan (GMEP).